Literature DB >> 6487181

A ten-year hospital survey of eyelid cancer.

I C Francis, P S Benecke, M B Kappagoda.   

Abstract

Two hundred and four cases of malignant eyelid tumours, managed at the Concord Hospital, were reviewed. These cases spanned a ten-year period between 1973 and 1982 and all were treated surgically. The nature of each tumour was confirmed by histopathological examination. Included in this review were the site of the tumour, the tumour pathology, the surgical management, the type of surgeon involved, the ocular complications, the management of recurrences and any mortality. The importance of preventing recurrences by adequate initial surgery with frozen section control is emphasized.

Entities:  

Mesh:

Year:  1984        PMID: 6487181

Source DB:  PubMed          Journal:  Aust J Ophthalmol        ISSN: 0310-1177


  5 in total

1.  Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries.

Authors:  Hiroshi Takamura; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

2.  Incidence of eyelid cancers in Singapore from 1968 to 1995.

Authors:  S B Lee; S M Saw; K G Au Eong; T K Chan; H P Lee
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Malignant eyelid tumors in Hong Kong 1997-2009.

Authors:  Shiu Ting Mak; Albert Chak-Ming Wong; Ida Yu-Fong Io; Raymond Kwok-Kay Tse
Journal:  Jpn J Ophthalmol       Date:  2011-08-13       Impact factor: 2.447

4.  Squamous cell carcinoma of the eyelids.

Authors:  M J Donaldson; T J Sullivan; K J Whitehead; R M Williamson
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

5.  Results of radical radiotherapy for squamous cell carcinoma of the eyelid.

Authors:  Koji Inaba; Yoshinori Ito; Shigenobu Suzuki; Shuhei Sekii; Kana Takahashi; Yuuki Kuroda; Naoya Murakami; Madoka Morota; Hiroshi Mayahara; Minako Sumi; Takashi Uno; Jun Itami
Journal:  J Radiat Res       Date:  2013-06-07       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.